hydroxyindoleacetic acid has been researched along with Clerambault Syndrome in 16 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (43.75) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobsen, JP | 1 |
| Weikop, P | 1 |
| Hansen, HH | 1 |
| Mikkelsen, JD | 1 |
| Redrobe, JP | 1 |
| Holst, D | 1 |
| Bond, CT | 1 |
| Adelman, JP | 1 |
| Christophersen, P | 1 |
| Mirza, NR | 1 |
| Jönsson, EG | 1 |
| Saetre, P | 1 |
| Edman-Ahlbom, B | 1 |
| Sillén, A | 1 |
| Gunnar, A | 1 |
| Andreou, D | 1 |
| Agartz, I | 1 |
| Sedvall, G | 1 |
| Hall, H | 1 |
| Terenius, L | 1 |
| Gilligan, J | 1 |
| Lee, B | 1 |
| Sullivan, PA | 1 |
| Murnaghan, D | 1 |
| Callaghan, N | 1 |
| Kantamaneni, BD | 1 |
| Curzon, G | 1 |
| Banki, CM | 1 |
| Molnár, G | 2 |
| Young, JG | 1 |
| Cohen, DJ | 1 |
| Shaywitz, SE | 1 |
| Caparulo, BK | 1 |
| Kavanagh, ME | 1 |
| Hunt, RD | 1 |
| Leckman, JF | 1 |
| Anderson, GM | 1 |
| Detlor, J | 1 |
| Harcherik, D | 1 |
| Shaywitz, BA | 1 |
| Bergqvist, PB | 1 |
| Some, M | 1 |
| Apelqvist, G | 1 |
| Helander, A | 1 |
| Bengtsson, F | 1 |
| Meyer, JS | 1 |
| Welch, KM | 1 |
| Deshmukh, VD | 1 |
| Perez, FI | 1 |
| Jacob, RH | 1 |
| Haufrect, DB | 1 |
| Mathew, NT | 1 |
| Morrell, RM | 1 |
| Bryer, JB | 1 |
| Starkstein, SE | 1 |
| Votypka, V | 1 |
| Parikh, RM | 1 |
| Price, TR | 1 |
| Robinson, RG | 1 |
| Degrell, I | 2 |
| Nagy, E | 2 |
| Joborn, C | 1 |
| Hetta, J | 1 |
| Niklasson, F | 1 |
| Rastad, J | 1 |
| Wide, L | 1 |
| Agren, H | 1 |
| Akerström, G | 1 |
| Ljunghall, S | 1 |
| Siever, LJ | 1 |
| Kahn, RS | 1 |
| Lawlor, BA | 1 |
| Trestman, RL | 1 |
| Lawrence, TL | 1 |
| Coccaro, EF | 1 |
| Percy, AK | 1 |
| Zoghbi, H | 1 |
| Riccardi, VM | 1 |
| O'Shanick, GJ | 1 |
| Fodor, A | 1 |
| Karczag, I | 1 |
| Szilágyi, A | 1 |
| Ujvárosi, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00004325] | 200 participants | Observational | 1988-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for hydroxyindoleacetic acid and Clerambault Syndrome
| Article | Year |
|---|---|
The psychopharmacologic treatment of violent youth.
Topics: Adolescent; Antipsychotic Agents; Child; Humans; Hydroxyindoleacetic Acid; Hyperthyroidism; Mental D | 2004 |
Critical issues in defining the role of serotonin in psychiatric disorders.
Topics: Animals; Humans; Hydroxyindoleacetic Acid; Mood Disorders; Neurocognitive Disorders; Serotonin | 1991 |
Neuropsychiatric complications in head injury.
Topics: Amnesia; Attention; Brain; Brain Chemistry; Cognition; Coma; Craniocerebral Trauma; Electroencephalo | 1986 |
13 other studies available for hydroxyindoleacetic acid and Clerambault Syndrome
| Article | Year |
|---|---|
SK3 K+ channel-deficient mice have enhanced dopamine and serotonin release and altered emotional behaviors.
Topics: Animals; Anti-Bacterial Agents; Anxiety Disorders; Behavior, Animal; Brain; Citalopram; Dopamine; Do | 2008 |
Brain-derived neurotrophic factor gene variation influences cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol concentrations in healthy volunteers.
Topics: Adult; Brain; Brain Chemistry; Brain-Derived Neurotrophic Factor; DNA Mutational Analysis; Female; G | 2008 |
Effect of dialysis on plasma and CSF tryptophan and CSF 5-hydroxyindoleacetic acid in advanced renal disease.
Topics: Adult; Fatty Acids, Nonesterified; Heparin; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Neu | 1980 |
Cerebrospinal fluid 5-hydroxyindoleacetic acid as an index of central serotonergic processes.
Topics: Adult; Aged; Alcoholism; Brain; Depressive Disorder; Epilepsy; Female; Humans; Hydroxyindoleacetic A | 1981 |
Assessment of brain function in clinical pediatric research: behavioral and biological strategies.
Topics: Catecholamines; Child; Child Behavior Disorders; Developmental Disabilities; Ethics, Medical; Homova | 1982 |
Elevated brain 5-hydroxytryptophol levels in experimental portal-systemic encephalopathy.
Topics: Animals; Brain; Hydroxyindoleacetic Acid; Hydroxytryptophol; Male; Neurocognitive Disorders; Portaca | 1997 |
Neurotransmitter precursor amino acids in the treatment of multi-infarct dementia and Alzheimer's disease.
Topics: 5-Hydroxytryptophan; Aged; Alzheimer Disease; Carbidopa; Dementia; Dopamine; Drug Combinations; Fema | 1977 |
Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report.
Topics: Adult; Aged; Cerebral Infarction; Depressive Disorder; Dominance, Cerebral; Female; Homovanillic Aci | 1992 |
Concentration gradients for HVA, 5-HIAA, ascorbic acid, and uric acid in cerebrospinal fluid.
Topics: Adult; Aged; Alcohol Amnestic Disorder; Ascorbic Acid; Brain; Dementia; Female; Homovanillic Acid; H | 1990 |
Correlations between cisternal CSF and plasma concentrations of HVA, MHPG, 5-HIAA, DA, and NA.
Topics: Adult; Aged; Aged, 80 and over; Blood-Brain Barrier; Brain; Brain Diseases; Dopamine; Female; Glycol | 1990 |
Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism.
Topics: Blood-Brain Barrier; Calcium; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Hyperparathyroidi | 1991 |
Rett syndrome: initial experience with an emerging clinical entity.
Topics: Adolescent; Biopsy; Child; Child Development; Child, Preschool; Electroencephalography; Female; Homo | 1985 |
5-Hydroxyindoleacetic acid in cerebrospinal fluid.
Topics: Adult; Age Factors; Brain Diseases; Brain Stem; Depression; Epilepsy; Humans; Hydroxyindoleacetic Ac | 1973 |